Related Experiment Video
Updated: Nov 9, 2025
Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
Advances in studies on exosomes and microvesicles as markers of cardiovascular disease
1Research Core Facility, West China Hospital, Sichuan University, Chengdu, Sichuan, China. wusisi@wchscu.cn.
Insights
Extracellular vesicles (EVs), including exosomes and microvesicles, show promise as novel biomarkers for cardiovascular diseases. These vesicles transmit vital information, aiding in the diagnosis of these high-mortality conditions.
Area of Science:
- Biomedical Science
- Cardiovascular Research
- Cell Biology
Background:
- Cardiovascular diseases (CVDs) are a leading cause of global mortality.
- Despite advances, new diagnostic biomarkers and treatments for CVDs are urgently needed.
- Extracellular vesicles (EVs) are increasingly recognized for their role in intercellular communication.
Purpose of the Study:
- To review the role of EVs in cardiovascular disease.
- To summarize signaling pathways involving exosomes and microvesicles (MVs) in CVDs.
- To discuss the diagnostic applications of EVs in cardiovascular conditions.
Main Methods:
- Literature review of studies on EVs in cardiovascular diseases.
- Analysis of signaling pathways mediated by exosomes and MVs.
- Evaluation of current and potential diagnostic applications of EVs.
Main Results:
- EVs, particularly exosomes and MVs, carry protein and genetic information between cells.
- These vesicles play significant roles in various signaling pathways relevant to CVDs.
- EVs demonstrate potential as valuable diagnostic biomarkers for cardiovascular diseases.
Conclusions:
- EVs represent a promising avenue for novel diagnostic biomarkers in cardiovascular medicine.
- Understanding EV signaling pathways can lead to improved diagnostic strategies for CVDs.
- Further research into EVs could enhance the early detection and management of cardiovascular diseases.
Abstract:
Cardiovascular diseases lead to one of the diseases with high mortality worldwide. Although considerable progress has been made in the diagnosis, treatment and prognosis of cardiovascular disease, there is still an urgent need for new diagnostic biomarkers and new treatments to reduce the incidence and mortality of the disease. In recent years, there has been increasing evidence that extracellular vesicles (EVs), especially exosomes and microvesicles (MVs) can be used as diagnostic biomarkers of protein and genetic information transmitted between adjacent and distant cells. This article summarizes various signal transmission pathways of exosomes and MVs in cardiovascular diseases, as well as their application and suggestions in the diagnosis of cardiovascular diseases.
More Related Videos
09:01Uptake of Fluorescent Labeled Small Extracellular Vesicles In Vitro and in Spinal Cord
Published on: May 23, 2021
08:13Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
Published on: April 10, 2019
Related Concept Videos
01:36Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...